Durbin Leads Senators In Demanding Answers From Pfizer, Eli Lilly On New Telehealth Platforms Amid Concerns Of Inappropriate Prescribing
October 22, 2024
October 22, 2024
WASHINGTON, Oct. 22 -- Sen. Richard J. Durbin, D-Illinois, issued the following news release:
In Letters to Pfizer and Eli Lilly, Durbin, Sanders, Welch, and Warren request details about whether the companies' new advertising & telehealth schemes create conflicts of interest that steer patients toward particular medications
CHICAGO U.S. Senate Majority Whip Dick Durbin (D-IL) sent a letter to the CEOs of Pfizer Inc. and Eli Lilly demanding answers about the pharmace . . .
In Letters to Pfizer and Eli Lilly, Durbin, Sanders, Welch, and Warren request details about whether the companies' new advertising & telehealth schemes create conflicts of interest that steer patients toward particular medications
CHICAGO U.S. Senate Majority Whip Dick Durbin (D-IL) sent a letter to the CEOs of Pfizer Inc. and Eli Lilly demanding answers about the pharmace . . .